Skip to main content
Cyfuse Biomedical K.K. (TYO:4892)
Japan flag Japan · Delayed Price · Currency is JPY
711.00
+1.00 (0.14%)
Apr 28, 2026, 3:30 PM JST

Cyfuse Biomedical K.K. Revenue

In the year 2025, Cyfuse Biomedical K.K. had annual revenue of 230.00M JPY with 325.93% growth. Cyfuse Biomedical K.K. had revenue of 169.00M in the quarter ending December 31, 2025, with 503.57% growth.

Revenue
230.00M
Revenue Growth
+325.93%
P/S Ratio
30.80
Revenue / Employee
10.00M
Employees
23
Market Cap
7.08B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025230.00M176.00M325.93%
Dec 31, 202454.00M-7.00M-11.48%
Dec 31, 202361.00M-313.00M-83.69%
Dec 31, 2022374.00M-334.00M-47.18%
Dec 31, 2021708.00M571.00M416.79%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SymBio Pharmaceuticals 1.31B
WDB coco 4.98B
Nippon Chemiphar 32.52B
Morishita Jintan 12.87B
Solasia Pharma K.K. 429.00M
MedRx 128.00M
Wakamoto Pharmaceutical 9.43B
Taiko Pharmaceutical 6.40B
Revenue Rankings